Loading...
First Round of Abstract Submission Ends: Jan 30, 2025
Extended Early Bird Ends: Sep 30, 2024

Plenary Speakers

Prof. Wayne W. Hancock
University of Pennsylvania, USA
Title: Will be updated soon
Wayne W. Hancock is a tenured Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and Chief of the Division of Transplant Immunology at the Children’s Hospital of Philadelphia. He has long-standing interests in transplant and cancer immunobiology and currently focuses on understanding the biology of Foxp3+ Tregs, with the hope that biochemical, pharmacologic and epigenetic studies of murine and human Tregs might lead to practical ways to regulate their activities. He has published >80 papers on murine and human Tregs and has an H-index of 122.
Prof. Angel Porgador
Ben-Gurion University of the Negev, Israel
Title: Immunotherapy of cancer
Prof. Angel Porgador is the incumbent of the Albert Katz Chair in Cell Differentiation and Malignant Diseases, and a member of the Shraga Segal Department of Microbiology, Immunology and Genetics and the National Institute for Biotechnology in the Negev. He served as Deputy Vice President and Dean for Research and Development until his recent election as the Dean of the Faculty of Health Sciences. Since the outbreak of the coronavirus, Prof. Porgador has led the interdisciplinary Corona Task Force established by BGU President, Prof. Daniel Chamovitz. He also heads a team of University researchers who have developed a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing, ultimately helping to prevent the spread of the disease by identifying these patients sooner and at a lower cost using significantly fewer tests. Prof. Porgador is a world renowned researcher in cancer and viral infections. His research focuses on innate immunity of health and disease. In much broader terms, he also investigates prolongation of protein lifespans in a host and the direct killing of tumor cells. He has published more than 130 papers in scientific journals. He holds a B.A with honors in basic medical sciences and an additional B.A in Computer Science and Mathematics from the Hebrew University of Jerusalem. He completed his M.A and Ph.D. in Life Sciences at the Weizmann Institute of Science. His postdoctoral fellowship was at Duke University and the American Institutes of Health (NIH). Porgador has served as President of the Israel Immunological Society and as the President of the Israeli Society for Cancer Research. In his role as Dean, he intends to position the faculty as a leader both in Israel and worldwide, strengthen research and recruit outstanding faculty members. Implementing new and innovative teaching methods is also high on his list of priorities, along with encouraging collaborative research projects, setting up community projects to promote good health and the training of a future generation in the Beer-Sheva spirit.
Prof. Poli Guido
Title: Will be upload soon
After my graduation as M.D in 1982, I joined the Laboratory of Human Immunology (Head: Alberto Mantovani) at the “Mario Negri” Institute for Pharmacological Research in Milano, Italy in 1983 where we published some of the earlier studies on the role of innate immunity in AIDS, an emerging deadly pandemic caused by HIV. In 1986, I moved to the Laboratory of Immunoregulation (Head: Anthony S. Fauci) at the NIAID, NIH, focusing on the role of cytokines as regulators of HIV latency and replication for which we established some of the earliest in vitro models for which I received the NIH Award of Merit in 1992 and the ESCI Award in 1999. In 1994, I was appointed Head of the AIDS Immunopathogenesis Unit (renamed in 2021 as “Human Immuno-Virology, H.I.V.”) at the San Raffaele Scientific Institute in Milano. In 2002, I became Associate Professor of Pathology at the San Raffaele University School of Medicine in Milano (promoted to Full Professor in 2016) while maintaining the role of research Unit Head. I am or have been Associate Editor/Editorial Board of several scientific journals (PlosOne, AIDS, J. of Immunology, Frontiers series, etc.). Thus far, I have authored or co-authored 244 indexed scientific publications plus additional 40 papers (174 original articles and 110 reviews/book chapters/editorials) collecting 11.993 citations and an h-index of 58 (source: Scopus). I have also co-edited two books on “Human Retroviruses. Methods and Protocols” and “HIV Reservoirs. Methods and Protocols” for Springer Protocols (Humana Press) in 2013 and 2022, respectively.